Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Bendamustine/Rituximab Induction Followed by Venetoclax/Rituximab Consolidation in Frontline Treatment of Chronic Lymphocytic Leukemia: A Phase 2 Multi-Center Study.
Journal: Hematological oncology
Published: January 06, 2026
Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years.
Journal: The Journal of allergy and clinical immunology
Published: December 16, 2025
Treatment-emergent coagulopathy during azacitidine/venetoclax induction in AML.
Journal: Blood neoplasia
Published: October 07, 2025
Imatinib-induced rhabdomyolysis: A case report.
Journal: Leukemia research reports
Published: September 10, 2025
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activation.
Journal: The Journal of allergy and clinical immunology
Published: April 21, 2025
Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 28, 2023
Circulating cancer giant cells with unique characteristics frequently found in patients with myelodysplastic syndromes (MDS).
Journal: Medical oncology (Northwood, London, England)
Published: May 18, 2023
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 08, 2023
Last Updated: 09/26/2026